This forum is for the discussion of anything to do with Prostate Cancer. There are only four rules:
No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
No harvesting e-mail addresses for Spam;
No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making
Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.
Since this is an International Forum, please specify your location in your post.
This is not necessarily all possible drugs used within the war on PCa, this is why onco-docs are needed, to figure out which, when, how much, the benefits, risks, rewards, side effects, pricing, etc. There are some newer drugs coming (listed above)that appear to be beneficial, some are supposed to be here between now and 2010 for making FDA approval, it is being said.
-I'm tired of thinking of all these drugs, but it is warfare on PCa and patients are looking for answers.
You will realize that even for an informed onco-doc or PCa onco-doc this is an omnious amount of possible use methodologies to be used on patients, especially with selective needs, issues, histology and such. Most uro-docs use the norm of LHRH (types), casodex (types) maybe even proscar or avodart and usually that is the end of their list*.
I do not know much on these drugs other than: ADT3 combo, and some on the estrogenics (I have used such).
Dx-2002 bPsa 46.6 12/12 biop. all were 80-90%, gleasons 7,8,9's ct & bone scans showed clear (my story is herein mentors/experiences Rob Parsons) current psa is .36 (2009)
